An 82-year-old woman arrives at the emergency department via ambulance due to the sudden onset of severe respiratory distress that began 3 hours ago. Her medical history includes ischemic cardiomyopathy with a left ventricular ejection fraction of 40%, diet-controlled type 2 diabetes mellitus, and chronic obstructive pulmonary disease (COPD) for which she uses an as-needed bronchodilator. Yesterday, she was diagnosed with an uncomplicated urinary tract infection; urine culture results returned today showing *Escherichia coli* that is susceptible to all tested antibiotics, including the oral nitrofurantoin she is currently taking.
On arrival, her temperature is 37.2°C (99.0°F), blood pressure is 188/102 mm Hg, pulse is 114/min, and respirations are 28/min. Pulse oximetry shows 86% on room air. Physical examination reveals a patient in moderate distress, speaking in short sentences. The jugular venous pressure is estimated at 11 cm H2O. Chest auscultation reveals scattered expiratory wheezes and bilateral basilar crackles. Cardiac examination shows tachycardia with a regular rhythm and a distinct S3 gallop.
Laboratory results are as follows:
Leukocytes: 11,500/mm³
B-type natriuretic peptide: 1,350 pg/mL
Thyroid-stimulating hormone (TSH): 0.2 mU/L (normal: 0.5–5.0 mU/L)
Free thyroxine (T4): 0.6 ng/dL (normal: 0.9–1.7 ng/dL)
Arterial blood gas (on room air):
pH: 7.28
PaCO₂: 25 mm Hg
PaO₂: 55 mm Hg
HCO₃⁻: 11 mEq/L
Lactate: 4.2 mmol/L (normal: 0.5–1.0 mmol/L)
Which of the following is the most appropriate next step in the management of this patient?
- Intravenous furosemide and noninvasive positive pressure ventilationCevap
- BInhaled albuterol and intravenous methylprednisolone
- CIntravenous piperacillin-tazobactam
- DIntravenous levothyroxine
- EIntravenous sodium bicarbonate